Drug · DIN 02484129
LENVIMA
EACH 12 MG DAILY DOSE CONTAINS 3 X 4 MG CAPSULES PER BLISTER
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since October 21, 2019; first marketed October 21, 2019.
- Drug Identification Number (DIN)
- 02484129
- Company (DIN owner)
- Eisai LimitedWoodcliff Lake, New Jersey, United States
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Lenvatinib L01EX08
- Class
- Human
- Record last updated
- August 25, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| LENVATINIB (LENVATINIB MESYLATE) | 12 MG | DOSE |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 19, 2018: NOC 21642Supplement to a New Drug Submission (SNDS) · New indication, New dosages
Other DINs named LENVIMA
- DIN 02450291 · Marketed
- DIN 02450305 · Marketed
- DIN 02450313 · Marketed
- DIN 02450321 · Marketed
- DIN 02468220 · Marketed
- DIN 02468239 · Marketed
- DIN 02484056 · Marketed